Skip to main content
Premium Trial:

Request an Annual Quote

Diversa Raises $20 Million Financing, Wins Cancer Institute Award

Premium

SAN DIEGO, Calif.--Diversa received a $100,000 Small Business Innovative Research award from the National Cancer Institute and more than $20 million in venture capital financing, half of that from four new investors: New York Life Insurance, State of Michigan Retirement Fund, Benefit Capital Management, and CSK Venture Capital.

With the NCI award, Diversa will further its search for pharmaceutical compounds from uncultivated microorganisms inhabiting diverse environments. Researchers will develop methods to isolate, identify, and replicate DNA from these microorganisms that may encode potentially therapeutic bioactive molecules, according to Diversa CEO Terrance Bruggeman.

Since it was founded in 1994, the corporation has raised close to $50 million in financing and become a leader in the discovery of high-value enzymes and bioactive compounds for the pharmaceutical, agricultural, and specialty chemical industries.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.